Brexpiprazole (OPC-34712) vs aripiprazole in adults with acute schizophrenia: a multicenter, randomized, open-label, flexible-dose, exploratory study

被引：0
|
作者：
Citrome, L. [1 ]
Ota, A. [2 ]
Nagamizu, K. [2 ]
Perry, P. [3 ]
Weiller, E.
Baker, R. [4 ]
机构：
[1] New York Med Coll, Psychiat & Behav Sci, Suffern, NY USA
[2] Otsuka Pharmaceut Co Ltd, CNS, Tokyo, Japan
[3] Otsuka Pharmaceut Dev & Commercializat Inc, Clin Management, Princeton, NJ USA
[4] Otsuka Pharmaceut Dev & Commercializat Inc, CNS Global Med Affairs, Princeton, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
10.1016/S0924-977X(15)30711-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.063
引用
下载
收藏
页码：S516 / S517
页数：2
相关论文
共 50 条
  • [1] The Effect of Brexpiprazole (OPC-34712) versus Aripiprazole in Adult Patients with Acute Schizophrenia: An Exploratory Study
    Citrome, Leslie
    Ota, Ai
    Nagamizu, Kazuhiro
    Perry, Pamela
    Weiller, Emmanuelle
    Baker, Ross
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09)
  • [2] The effect of brexpiprazole (OPC-34712) versus aripiprazole in adult patients with acute schizophrenia: an exploratory study
    Citrome, Leslie
    Ota, Ai
    Nagamizu, Kazuhiro
    Perry, Pamela
    Weiller, Emmanuelle
    Baker, Ross
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 189 - 190
  • [3] The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study
    Citrome, Leslie
    Ota, Ai
    Nagamizu, Kazuhiro
    Perry, Pamela
    Weiller, Emmanuelle
    Baker, Ross A.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (04) : 192 - 201
  • [4] FLEXIBLE-DOSE BREXPIPRAZOLE AS MAINTENANCE TREATMENT IN ADOLESCENTS WITH SCHIZOPHRENIA: A LONG-TERM, MULTICENTER, OPEN-LABEL STUDY
    Chumki, Sanjeda
    Hefting, Nanco
    Wang, Fan
    Ward, Caroline
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (10): : S141 - S141
  • [5] The effect of brexpiprazole (OPC-34712) in adult outpatients with early-episode schizophrenia: An exploratory study
    Weiss, C.
    Sugaya, K.
    Perry, P.
    Nagamizu, K.
    Weiller, E.
    Baker, R.
    Malla, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S521 - S522
  • [6] Long-term safety of brexpiprazole (OPC-34712) in schizophrenia: results from two 52-week open-label studies
    Correll, Christoph U.
    Skuban, Aleksandar
    Ouyang, John
    Weiller, Emmanuelle
    Weiss, Catherine
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 190 - 190
  • [7] LONG-TERM SAFETY OF BREXPIPRAZOLE (OPC-34712) IN SCHIZOPHRENIA: RESULTS FROM TWO 52-WEEK OPEN-LABEL STUDIES
    Correll, Christoph Ulrich
    Skuban, Aleksandar
    Ouyang, John
    Weiller, Emmanuelle
    Weiss, Catherine
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S307 - S307
  • [8] Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study
    Fleischhacker, W. Wolfgang
    Hobart, Mary
    Ouyang, John
    Forbes, Andy
    Pfister, Stephanie
    McQuade, Robert D.
    Carson, William H.
    Sanchez, Raymond
    Nyilas, Margareta
    Weiller, Emmanuelle
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2017, 20 (01): : 11 - 21
  • [9] Long-term safety of adjunctive brexpiprazole (OPC-34712) in MDD: results from two 52-week open-label studies
    Nelson, Craig
    Skuban, Aleksandar
    Zhang, Peter
    Weiller, Emmanuelle
    Weiss, Catherine
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 103 - 103
  • [10] Brexpiprazole (OPC-34712) efficacy and safety as maintenance therapy in adults with schizophrenia: Randomised, double-blind, placebo-controlled study
    Fleischhacker, W. W.
    Hobart, M.
    Ouyang, J.
    Forbes, A.
    Pfister, S.
    McQuade, R.
    Carson, W. H.
    Sanchez, R.
    Nyilas, M.
    Weiller, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S527 - S527
12345